CureVac Covid Vaccine Shows Immune Response in Early Trial

Bookmark
(Bloomberg) -- A coronavirus vaccine under development from CureVac NV showed a good immune response in early trials, validating the biotech company’s 20 years of research into messenger RNA’s abil...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.